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ABSTRACT Mutants of Salmonella typhimurium lacking
DNA adenine methylase are attenuated for virulence in
BALByc mice. LD50 values of a DNA adenine methylation
(Dam)2 mutant are at least 103- to 104-fold higher than those
of the parental strain when administrated by oral or intra-
peritoneal routes. Dam2 mutants are unable to proliferate in
target organs but persist in low numbers in these locations.
Efficient protection to challenge with the virulent parental
strain is observed in mice infected with a Dam2 mutant. Use
of the ileal loop assay shows that Dam2 mutants are less
cytotoxic to M cells and fail to invade enterocytes. In the tissue
culture model, lack of DNA adenine methylation causes re-
duced ability to invade nonphagocytic cells. In contrast, no
effect is observed either in intracellular proliferation within
nonphagocytic cells or in survival within macrophages. The
invasion defect of Dam2 mutants is correlated with a distinct
pattern of secreted proteins, which is observed in both PhoP1
and PhoP2 backgrounds. Altogether, our observations suggest
a multifactorial role of Dam methylation in Salmonella viru-
lence.
In the bacterial cell, DNA adenine methylation (Dam) mod-
ulates a variety of processes such as DNA replication, chro-
mosome segregation, mismatch repair, and transcription of
certain genes (1–3). Given these multiple roles, it is not
surprising that dam mutations are highly pleiotropic; however,
lack of Dam methylation does not impair viability (1, 3, 4). The
existence of genes whose transcription is regulated by Dam
methylation has been known for two decades in Escherichia
coli and its phages (1–3), and novel cases have recently been
described in Salmonella typhimurium (4–6). Genes regulated
by Dam methylation usually contain GATC sites either in their
promoter or in upstream regulatory sequences. The methyl-
ation state of these GATC sites controls the interaction
between RNA polymerase or regulatory proteins and their
cognate DNA-binding sites (1, 7). A paradigmatic case of
transcriptional regulation by Dam methylation is the E. coli pap
operon, which directs the synthesis of pili required for adhesion
to uroepithelial cells. In uropathogenic E. coli, expression of
pap is subjected to phase variation (8, 9). The ON and OFF
stages are dictated by binding of the regulatory protein Lrp and
accessory proteins to two GATC sites upstream of the tran-
scription initiation site (8, 10). Recent work has shown that
expression of other E. coli operons encoding virulence-related
fimbriae, such as sfa, daa, and fae, are also regulated by Lrp
binding (11, 12). As in the pap operon, Lrp mediates tran-
scriptional control over these fimbrial operons depending on
the methylation status of critical GATC sites (11, 12).
Dam2 mutants of Salmonella typhimurium were recently
described (4). The same study showed that Dam methylation
regulates the expression of a locus in the S. typhimurium
virulence plasmid (4). This finding and the fact that Dam
methylation modulates the expression of virulence-related
fimbriae in E. coli (10) led us to examine whether Dam
methylation could play a role in S. typhimurium virulence.
Tests in the BALByc murine model were unambiguous: ab-
sence of DNA adenine methylation produces severe attenua-
tion of S. typhimurium virulence. A partial defect in the
capacity of S. typhimurium to invade nonphagocytic cells is also
observed. Furthermore, Dam2 mutants are unable to invade
enterocytes and to cause cytotoxicity on M cells of ileal Peyer’s
patches. Our conclusion that DNA adenine methylation plays
a major role in S. typhimurium virulence is supported by the
recent finding that Dam2 mutants of Salmonella show altered
expression of a number of in vivo-induced genes (6).
MATERIALS AND METHODS
Bacterial Strains, Plasmids, Growth Media, and Growth
Conditions. S. typhimurium SL1344 was used as the standard
virulent strain (13). Strains SV1610 (SL1344 dam-228::MudJ),
SV4036 (mutL111::Tn10), SV4056 (phoP7953::Tn10) and
SV4089 (dam-228::MudJ phoP7953::Tn10), all derived from
SL1344, are described in this study. The allele mutL111::Tn10
was obtained from G. C. Walker, Massachusetts Institute of
Technology, Cambridge, MA. The allele phoP7953::Tn10 was
provided by E. A. Groisman, Washington University, St. Louis,
MO. Plasmid pTP166, obtained from M. G. Marinus, Univer-
sity of Massachusetts, Worcester, MA, is a ColE1 derivative
harboring the wild-type dam gene of E. coli under the control
of a tac promoter (14). Noninvasive S. typhimurium strains
SB220 (SL1344 sipC::aph) and SB302 (SL1344 invJ::aph) were
provided by J. E. Gala´n, Yale University, New Haven, CT (15,
16). Strains were grown overnight in LB broth at 37°C without
shaking before administration to BALByc mice, infection of
tissue culture cells, or preparation of extracts containing
secreted proteins (see below). Solid LB contained 1.5% Difco
agar. Green plates were prepared as described elsewhere (4).
Virulence and Vaccination Assays in BALByc Mice. Bacte-
ria were centrifuged at 10,000 3 g for 15 min and washed twice
in sterile PBS. Serial dilutions were used to infect orally (25 ml)
or intraperitoneally (200 ml) groups of 8-wk-old female
BALByc mice. In oral challenge experiments, the acidic pH of
the stomach was buffered by suspending bacteria in a 2.5%
bicarbonate–0.2% lactose solution before administration. Sur-
vival of infected mice was recorded for a minimum of 4 wk.
LD50 was calculated by the method of Reed and Muench (17).
In vaccination studies 4 wk after infection with the S. typhi-
murium Dam2 mutant SV1610, mice were challenged orally
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with different doses of the parental virulent strain SL1344.
Mouse survival was recorded for 4 additional weeks. In organ
colonization studies, lymph nodes, liver, and spleen were
removed from two mice at each postinfection time and ho-
mogenized in 10 ml of sterile PBS. Dilutions of these homog-
enates were plated on LB to count the numbers of viable
bacteria per organ.
Ligated Loop Model and Electron Microscopy. Interaction
of wild-type and Dam2 bacteria with murine intestinal epi-
thelium was examined as described by Jones et al. (18). Briefly,
7-wk-old BALByc mice were starved for 24 h and anesthetized
before surgery by i.p. injection of 2.0 mg of Nembutal. On
practicing a small incision, the small bowel was exposed, and
a loop was formed by ligating the intestine with silk thread at
the ileocaecal junction and at a site 5 cm proximal to the
caecum. Two hundred microliters of bacteria (ca. 4 3 108
colony-forming units) were then injected through a 25-gauge
needle. The bowel was returned to the abdomen and the
incision stapled. Mice were kept alive for 3 h and then
sacrificed. The bacteria-exposed intestinal loop was removed,
and sections containing Peyer’s patches were fixed in a solution
of 2.5% glutaraldehydey0.8% paraformaldehyde in 0.1 M
phosphate buffer. After 15 min, Peyer’s patches were displayed
in fresh fixing solution for an additional hour. Postfixation was
made with 0.1% osmium tetroxide for 1 h. After three washes
with phosphate buffer, samples were dehydrated with ethanol
and propylene oxide. Infiltration and embedding was achieved
with Epon resin. Resin polymerization was allowed for 48 h at
60°C. Ultrathin sections were contrasted with uranyl acetate
and lead and examined in a JEOL1200EX electron micro-
scope.
Eukaryotic Cell Lines. HeLa epithelial cells (ATCC CCL2)
and J774.A1 mouse macrophages were used as prototypes of
nonphagocytic and phagocytic cells, respectively. Mouse res-
ident peritoneal macrophages were harvested from BALByc
mice as described by Leung and Finlay (19). Cells were grown
in MEM containing 10% fetal bovine serum (HeLa epithelial
cells) or in DMEM containing 5% fetal bovine serum and 1
mM glutamine (macrophages).
Bacterial Infection of Eukaryotic Cells. Eukaryotic cells
were seeded the day before the infection in 24-well plates and
grown at 37°C, 5% CO2 to obtain 80% confluency. Bacteria
were added to reach a multiplicity of infection of 10:1 bacteriay
eukaryotic cell. Eukaryotic cells were infected for 15 min
(HeLa epithelial cells), 20 min (resident peritoneal macro-
phages), or 10 min (J774.A1 macrophages) to obtain an
infection rate of 70–80% of the cells present. Infected cells
were washed three times with PBS and incubated in fresh tissue
culture medium containing 100 mgyml gentamicin. Two hours
postinfection, the concentration of gentamicin was lowered to
10 mgyml. Numbers of viable intracellular bacteria were ob-
tained by lysing infected cells with 1% Triton X-100 and
subsequent plating (20). Invasion rates of nonphagocytic cells
were determined as the ratio of viable intracellular bacteria at
a short postinfection time (2 h) vs. viable bacteria added to
infect the eukaryotic cells.
Extracts of Secreted Bacterial Proteins. Extracts of secreted
proteins were prepared by the method of Kaniga et al. (15).
Proteins were analyzed by SDSyPAGE in TrisyTricine buffer
by using 8% acrylamide gels (21).
RESULTS
S. typhimurium Dam2 Mutants Are Attenuated for Viru-
lence in the BALByc Mouse Model. To examine whether Dam
methylation is required for virulence in the murine typhoid
model, BALByc mice were infected with various doses of a
Dam2 strain of S. typhimurium (SV1610) by oral and i.p.
routes. In parallel, infections were performed with the virulent
strain SL1344 (13). Table 1 shows that LD50 values obtained
for the Dam2 mutant were over 8.8 3 108 bacteria (oral) and
6.5 3 104 bacteria (i.p.). No orally challenged mice died or
showed any symptom of disease during the course of the
experiment (4 wk). The LD50 values obtained (Table 1) were
at least 103- to 104-fold higher than those of the parental strain
SL1344, in agreement with a recent study (6). To confirm that
the attenuation of virulence observed in the Dam2 mutant was
exclusively caused by lack of Dam methylation, we constructed
a SV1610 derivative carrying plasmid pTP166, which contains
the wild-type dam gene from E. coli (14). The complemented
strain was fully virulent (Table 1). Complementation failed
when the strain carried high-molecular-weight multimers of
pTP166 (data not shown). The latter phenomenon was inter-
preted as an artifact and was not further investigated. How-
ever, the possibility that abnormally high levels of Dam
methylase might also cause virulence defects, as suggested by
Heithoff et al. (6), can be considered. Complementation of
virulence in the in vivo model shows that there is no polar effect
of the MudJ element inserted in the dam gene on hypothetical
virulence genes located downstream of dam. Altogether, these
data show that S. typhimurium requires Dam methylation to
cause disease in the murine model. Such a requirement is
unrelated to the mismatch repair deficiency of Dam strains,
because a MutL2 mutant (SV4036) proved to be virulent
(Table 1).
Colonization of Target Organs of Infected Mice by the S.
typhimurium Dam2 Mutant. Because there was no sign of
disease after oral and i.p. challenge with strain SV1610
(Dam2), we reasoned that Dam methylation could be required
for colonization of target organs. To test this possibility, mice
were infected orally and intraperitoneally. Lymph nodes, liver,
and spleen were harvested periodically from day 1 to 21 after
infection, and viable bacteria were counted by plating. Low
numbers of Dam2 bacteria, approximately 102–103, were
found in these organs 3 wk after infection (Fig. 1). In contrast,
the parental (virulent) strain SL1344 increased by a factor of
103–104 in number during the first week of infection (Fig. 1).
On i.p. challenge, Dam2 bacteria increased in number during
the first week, dropping afterward to a steady value of 102–103.
The complemented strain SV1610ypTP166 (dam-228::
MudJydam1) was likewise able to grow within organs on oral
administration (data not shown). Altogether, these data sug-
gest that DNA adenine methylation is essential for S. typhi-
murium to proliferate within target organs on oral and i.p.
administration.
A S. typhimurium Dam2 Mutant Elicits Protection to Chal-
lenge with the Virulent Strain. The fact that the Dam2 mutant
is able to persist, albeit in low numbers, in target organs for 3
wk (Fig. 1) led us to examine whether this attenuated strain
could elicit a specific immune response. Mice were infected
orally or intraperitoneally with different doses of strain
SV1610 (Dam2) and challenged 4 wk after infection with high
doses of the virulent strain SL1344. Table 2 shows that
infection of BALByc mice with the Dam2 mutant rendered the
animal capable of surviving to lethal doses of the virulent
strain. Of a total of 42 mice infected with the Dam2 mutant,
38 survived the challenge with an amount of virulent bacteria
up to 100-fold the LD50 (Table 2). Interestingly, as few as 89
Dam2 S. typhimurium cells administered by the i.p. route were
Table 1. Virulence properties of a S. typhimurium Dam2 mutant
in BALByc mice
Bacterial strain LD50 (oral)* LD50 (i.p.)
SL1344 (wild type) 6 3 104 ,10
SV1610 (Dam2) .8.8 3 108 6.5 3 104
SV1610ypTP166 2.75 3 105 ,35
SV4036 (MutL2) 2.4 3 106 ,17
*Oral inoculation was done by suspending bacteria in bicarbonate
buffer before administration to mice.
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capable of eliciting in the animal a specific immune response
against the virulent strain (Table 2).
Behavior of the S. typhimurium Dam2 Mutant in the Tissue
Culture Model. Dam2 mutants of S. typhimurium do not
exhibit growth defects in standard media (4). In addition, the
Dam2 strain used in this study, SV1610, shows a normal
serum-resistance response (F.G-P., unpublished work). There-
fore, we reasoned that attenuation of the Dam2 mutant might
reflect an impaired interaction of bacteria with host cells. To
test this hypothesis, we analyzed whether the Dam2 mutant
showed defects in invasion, survival, or growth within nonph-
agocytic and phagocytic cells. Table 3 shows that the Dam2
mutant is partially impaired for invading nonphagocytic cells
(30% of wild-type values in HeLa cells). The complemented
strain showed wild-type invasion ability (Table 3). Well known
invasion mutants such as SipC2 and InvJ2 yielded values less
than 1% (Table 3). The Dam2 mutant did not show any
proliferation defect within HeLa cells (Table 3). To test
whether Dam methylation was required for bacterial survival
within macrophages, both the mouse macrophage cell line
J774A.1 and mouse resident peritoneal macrophages were
used. As previously reported, strain SL1344 was able to
proliferate within J774A.1 and to survive within peritoneal
macrophages (ref. 22; see also Table 3). Neither the Dam2 nor
the Dam2yDam1 (complemented) strain showed any notice-
able defect in the interaction with macrophages (Table 3).
These data suggest that DNA adenine methylation is not
essential for bacteria to proliferate within nonphagocytic cells
or to survive within macrophages. In contrast, Dam methyl-
ation seems to be required to trigger an efficient bacterial
uptake by nonphagocytic cells.
Phenotype of a Dam2 Mutant in the Murine Intestinal
Epithelium. Because Dam2 mutants showed a partial defect in
invasion of cultured epithelial cells, we addressed the murine
ligated loop assay to monitor two critical events linked to
Salmonella penetration of the intestinal epithelium: cytotox-
icity on M cells of Peyer’s patches and invasion of enterocytes.
Elicitation of both processes has been shown to be related to
the invasion capacity observed in the in vitro models (23–25).
Disruption of M cell integrity was observed on 3 h of infection
with the wild type (Fig. 2 a and b). In contrast, very few Dam2
(SV1610) bacteria were seen interacting with M cells and, in
the rare cases observed, the presence of bacteria did not trigger
M cell cytotoxicity (Fig. 2c). Moreover, unlike the wild type,
Dam2 cells were not seen either causing massive destruction
of the intestinal epithelium or moving to deep locations close
to the lamina propria (Fig. 2d). Another distinct phenotype of
the Dam2 mutant was its impaired capacity to invade entero-
cytes (Fig. 2 e and f ). Altogether, these data suggest that Dam
methylation modulates the interaction of Salmonella with
different cell types in Peyer’s patches.
Secretion of Proteins in S. typhimurium Dam2 Mutants. The
virulence trait affected in Dam2 mutants, invasion of nonph-
agocytic cells, has been shown to depend on a specialized type
III secretion system (reviewed in refs. 26, 27). Type III-
secreted proteins have been identified in bacterial culture
media supernatants and shown essential for Salmonella inva-
sion (26, 27). We thus analyzed the protein content of super-
natants of the wild type, a Dam2 mutant, and a Dam1-
complemented strain. Extracts containing Salmonella-secreted
proteins (ssp) were examined by Coomassie staining. The
protein profile obtained for the Dam2 mutant was clearly
different, and at least three proteins found in the Dam2
mutant were not detectable in the wild type (Fig. 3). Inter-
estingly, the dam mutation causes a reduction in the secretion
of SPI-1 encoded effector proteins, such as SipA, SipB, and
SipC, whereas f lagellin secretion is unaffected (Fig. 3).
Complementation of the dam mutation fully restored the
profile of ssp observed in the wild type (Fig. 3).
Table 2. Protection conferred by a S. typhimurium Dam2 mutant
to challenge with the virulent strain
Experiment
Dose of SV1610
(Dam2)*
Challenge dose of
SL1344 (wt)†
No. dead micey
inoculated mice
1 — 2.8 3 103 1y5
— 2.8 3 104 1y5
— 2.8 3 105 4y5
2 2.5 3 106 1.2 3 106 1y4
2.5 3 107 1.2 3 106 1y4
2.5 3 108 1.2 3 106 0y4
3 7 3 106 9.7 3 106 0y5
7 3 107 9.7 3 106 1y5
7 3 108 9.7 3 106 0y5
89 (i.p.) 9.7 3 106 0y5
890 (i.p.) 9.7 3 106 0y5
8.900 (i.p.) 9.7 3 106 1y5
*Inoculations were done by the oral route, except when indicated i.p.
After 4 wk, all Dam2 infected mice survived the doses of bacteria
indicated.
†All inoculations were done by the oral route. In experiments 2 and 3,
challenges with the wild-type strain were done 4 wk after the
inoculation with the Dam2 mutant. Mouse survival was recorded for
4 additional weeks.
FIG. 1. Colonization of mouse organs by a S. typhimurium Dam2 mutant. Groups of 8-wk-old BALByc mice were infected orally with 8.8 3
108 colony-forming units (cfu) of the strain SV1610 (Dam2) [black histograms] or 7.5 3 105 cfu of strain SL1344 (wild type) [white histograms].
Another group of mice were infected intraperitoneally with 1.5 3 105 cfu of SV1610 (Dam2) [grey histograms]. At the times indicated, lymph nodes
(A), liver (B), and spleen (C) were removed from two infected mice, and viable bacteria were determined by plating. At 8 days after infection,
all the wild-type infected mice showed clear evidence of disease.
11580 Microbiology: Garcı´a-Del Portillo et al. Proc. Natl. Acad. Sci. USA 96 (1999)
Because an interconnection of regulons under Dam and
PhoP control has been recently postulated (6), we examined
the effect of dam and phoP mutations on secreted protein
profiles. In agreement with previous observations (28), a
PhoP2 mutant showed a wild-type profile of ssp. In contrast,
the ssp profile of a Dam2 PhoP2 double mutant was similar to
that of a Dam2 mutant (Fig. 3). Thus, the secretion defect of
Dam2 mutants is observed in both the presence and the
absence of the PhoP product. The observation that the role of
Dam methylation in secretion is PhoP independent can be
tentatively correlated with invasion assays in HeLa cells: a dam
mutation caused a similar invasion reduction in both PhoP1
and PhoP2 backgrounds (data not shown). Furthermore, we
investigated the involvement of Dam methylase on secretion of
SPI1-encoded proteins essential for invasion, such as SipC and
InvJ. Western analysis of ssp supernatant extracts by using
specific anti-SipC and -InvJ antibodies indicated that secretion
of both proteins is reduced by 50% in the Dam2 mutant (data
not shown). Globally, these assays suggest that Dam methyl-
ation might modulate the SPI-1 encoded type III secretion
system.
DISCUSSION
In the murine model, attenuation of S. typhimurium virulence
in the absence of Dam methylation is observed in both the oral
and the intraperitoneal routes. In vivo studies have also shown
that, on oral and i.p. administration, the Dam2 mutant is able
to colonize target organs, but not to proliferate in these
locations. The combination of attenuated virulence and organ
colonization ability makes Dam2 mutants excellent candidates
for vaccination. In fact, the Dam2 mutant used in this study
was able to elicit an immune response sufficient to prevent
killing by the virulent strain at doses 100-fold the LD50. Similar
observations have recently been reported by Heithoff et al. (6).
Given the high pleiotropy of dam mutations (1, 4), the
specific link(s) between Dam methylation and systemic disease
cannot be established a priori. However, insights were obtained
from the ileal ligated loop assay: the Dam2 mutant does not
cause cytotoxicity on M cells and is unable to invade entero-
cytes. These observations explain the low numbers of bacteria
recovered from target organs on oral challenge. The M cell has
been shown to play a critical role in the intestinal immune
response (29). Therefore, lack of cytotoxicity on M cells,
together with their proper stimulation by infecting Dam2
bacteria, can improve the host immune response and render
the Dam2 mutant avirulent. In fact, it is known that nonin-
vasive S. typhimurium mutants are avirulent because they do
not destroy M cells (30). These results can also explain the
optimal vaccine properties of Dam2 mutants observed by us
and by others (6).
Further insights on the role of Dam methylation in Salmo-
nella virulence were obtained from the tissue culture model: a
Dam2 mutant showed reduced capacity to invade HeLa cells.
However, the invasion impairment of a Dam2 mutant was only
partial, compared with a SPI1 secretion-deficient InvJ2 mu-
tant or a mutant lacking the effector invasion protein SipC.
These differences may indicate that a dam mutation causes
mild changes in the amount or the activity of these proteins,
compared with the effect of knocking out the corresponding
genes.
FIG. 2. Interaction of S. typhimurium Dam2 mutants with the
murine intestinal epithelium. The ligated loop assay was used to
examine the interaction of SL1344 (wild type) and SV1610 (Dam2)
with cell types present in Peyer’s patches 3 h after infection. Shown are
transmission electron micrographs of: (a) an uninfected M cell; (b) an
M cell disrupted by the infection of the wild-type strain; (c) Dam2
bacteria interacting with M cells; note the lack of cytotoxicity on the
M cell; (d) massive destruction of the intestinal epithelium, which now
appears with a clear gap (shown by arrows) as a result of infection by
wild-type bacteria. This generalized destruction was never observed in
loops infected with Dam2 bacteria; (e) wild-type bacteria internalized
by enterocytes; ( f) Dam2 bacteria that do not invade enterocytes. M,
M cell; E, enterocyte; L, lymphocyte; B, intracellular bacteria. Note
the presence of bacteria in deep locations only in tissues infected with
the wild-type strain (b and d). (a–d, 32,000; e and f, 33,000.)
Table 3. Phenotype of a Dam2 mutant in the tissue culture model
Strain Invasion, %†
Intracellular
proliferation‡
Survival in macrophages*
J774.A1
Mouse
peritoneal
SL1344 (wt) 100 6 23.8 25.3 6 5.05 6.85 6 0.3 0.41 6 0.13
SV1610 (Dam2) 28.4 6 9.2 16.1 6 3.4 7.7 6 1.65 0.22 6 0.12
SV1610ypTP166 105.4 6 33.9 28.9 6 0.3 10 6 0.53 0.33 6 0.05
(Dam2yDam1)
SB220 (SipC2) 0.43 6 0.05 ND ND ND
SB302 (InvJ2) 0.65 6 0.23 ND ND ND
pRatio of viable intracellular bacteria at 20 h vs. 0.5 h after infection. In both types of macrophages, cells
were infected for 10 min.
All values are averages of triplicate samples from at least two independent trials. ND, not determined.
†Percentage of bacteria that invade HeLa epithelial cells during 15 min and survived a gentamicin
protection assay. Plating was done at 2 h after infection. Values were normalized to invasion rate of
wild-type bacteria (0.109 6 0.02).
‡Ratio of viable intracellular bacteria at 24 h vs. 2 h after infection, obtained after incubating HeLa cells
with bacteria for 15 min.
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Because secreted proteins are well known effectors in the
interaction with eukaryotic cells (26), we considered the
possibility that absence of Dam methylation might cause
changes in protein secretion mediated by the SPI1 type III
system. To test this hypothesis, protein profiles were analyzed
in culture supernatants. A distinct pattern of protein secretion
was observed in the Dam2 mutant. The most relevant differ-
ences were: (i) the presence of proteins absent from wild-type
extracts and (ii) a reduction in the level of secreted SipA, SipB,
and SipC. No defect was observed in flagellin secretion,
implying that the effects observed are specific for secretion via
the virulence-related type III apparatus. To our knowledge,
this is the first description of a DNA modification mechanism
that influences secretion of virulence determinants. The effect
of Dam methylation on the SPI1 secretion system could be
exerted on structural or regulatory genes. Putative target
SPI-1-encoded regulators include HilA, InvF (31, 32), and the
recently described HilC and HilD (33). Alternatively, Dam
methylation could be essential for the activity of other regu-
lators acting on (but not encoded by) SPI1, such as SirA (34,
35) or PhoPQ (28).
Although our protein analyses imply a connection between
Dam methylation and the functionality of the SPI1 type III
secretion system, our virulence data clearly indicate that the
Dam2 mutant is also attenuated when administrated intra-
peritoneally. Because SPI1-defective mutants are still virulent
when tested by this route (30, 36, 37), other major virulence
genes involved in Salmonella systemic disease might be con-
trolled by Dam methylation. Putative candidates are compo-
nents of the second type III system encoded in SPI2 (38, 39)
or alternative sigma factors as RpoS (sS) or RpoE (sE) (40,
41). However, unlike mutants in these components or regula-
tors, which show clear defects in intracellular proliferation (38,
39) or intracellular survival within macrophages (38–41), our
study shows that Dam2 mutants are not deficient in these
processes. Therefore, further characterization of genes mod-
ulated by Dam methylation is required to ascertain which gene
products essential for systemic infection are affected in Dam2
mutants. A recent report by Heithoff et al. (6) proposes that a
large number of Dam-regulated virulence genes exist in S.
typhimurium, thus supporting our view that the effects of DNA
adenine methylase mutations on Salmonella virulence are
pleiotropic.
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